| NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines GD Demetri, RS Benjamin, CD Blanke, JY Blay, P Casali, H Choi, ... Journal of the National Comprehensive Cancer Network 5 (S2), S-1-S-29, 2007 | 1136 | 2007 |
| KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours M Debiec-Rychter, R Sciot, A Le Cesne, M Schlemmer, P Hohenberger, ... European journal of cancer 42 (8), 1093-1103, 2006 | 1124 | 2006 |
| Toward minimal residual disease-directed therapy in melanoma F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ... Cell 174 (4), 843-855. e19, 2018 | 663 | 2018 |
| Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II … M Debiec-Rychter, H Dumez, I Judson, B Wasag, J Verweij, M Brown, ... European journal of cancer 40 (5), 689-695, 2004 | 602 | 2004 |
| Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants M Debiec-Rychter, J Cools, H Dumez, R Sciot, M Stul, N Mentens, ... Gastroenterology 128 (2), 270-279, 2005 | 592 | 2005 |
| Clinical management of uterine sarcomas F Amant, A Coosemans, M Debiec-Rychter, D Timmerman, I Vergote The lancet oncology 10 (12), 1188-1198, 2009 | 559 | 2009 |
| Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225 GA McArthur, GD Demetri, A Van Oosterom, MC Heinrich, ... Journal of clinical oncology 23 (4), 866-873, 2005 | 553 | 2005 |
| PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t (X; 1)(p11. 2; q21) P Argani, CR Antonescu, J Couturier, JC Fournet, R Sciot, ... The American journal of surgical pathology 26 (12), 1553-1566, 2002 | 397 | 2002 |
| Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials P Rutkowski, M Van Glabbeke, CJ Rankin, W Ruka, BP Rubin, ... Journal of clinical oncology 28 (10), 1772-1779, 2010 | 396 | 2010 |
| Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma MR Tanas, A Sboner, AM Oliveira, MR Erickson-Johnson, J Hespelt, ... Science translational medicine 3 (98), 98ra82-98ra82, 2011 | 388 | 2011 |
| Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate H Prenen, J Cools, N Mentens, C Folens, R Sciot, P Schöffski, ... Clinical Cancer Research 12 (8), 2622-2627, 2006 | 369 | 2006 |
| Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor P Rutkowski, ZI Nowecki, W Michej, M Dębiec-Rychter, A Woźniak, ... Annals of surgical oncology 14, 2018-2027, 2007 | 351 | 2007 |
| The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor CH Lee, A Mariño-Enriquez, W Ou, M Zhu, RH Ali, S Chiang, F Amant, ... The American journal of surgical pathology 36 (5), 641-653, 2012 | 326 | 2012 |
| Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients O Maertens, H Prenen, M Debiec-Rychter, A Wozniak, R Sciot, P Pauwels, ... Human molecular genetics 15 (6), 1015-1023, 2006 | 281 | 2006 |
| Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity M Debiec‐Rychter, B Wasag, M Stul, I De Wever, A Van Oosterom, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 280 | 2004 |
| Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene … A Mohajeri, J Tayebwa, A Collin, J Nilsson, L Magnusson, FV von Steyern, ... Genes, Chromosomes and Cancer 52 (10), 873-886, 2013 | 279 | 2013 |
| Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors E Beert, H Brems, B Daniëls, I De Wever, F Van Calenbergh, ... Genes, Chromosomes and Cancer 50 (12), 1021-1032, 2011 | 267 | 2011 |
| 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma CH Lee, WB Ou, A Mariño-Enriquez, M Zhu, M Mayeda, Y Wang, X Guo, ... Proceedings of the National Academy of Sciences 109 (3), 929-934, 2012 | 264 | 2012 |
| Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors MC Heinrich, D Griffith, A McKinley, J Patterson, A Presnell, ... Clinical cancer research 18 (16), 4375-4384, 2012 | 250 | 2012 |
| Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST) A Gupta, S Roy, AJF Lazar, WL Wang, JC McAuliffe, D Reynoso, ... Proceedings of the National Academy of Sciences 107 (32), 14333-14338, 2010 | 249 | 2010 |
Agnieszka WozniakVerified email at med.kuleuven.be
